1. Introduction {#sec1}
===============

Pyelonephritis during pregnancy has the potential to cause serious morbidity to the pregnant woman. It is the most common nonobstetric indication for antepartum hospitalization, and its associated risk factors, diagnosis, and management in the antepartum period are well described \[[@B1]--[@B4]\]. Serious morbidity associated with pyelonephritis in pregnancy is common. Sepsis and septic shock occur secondary to pyelonephritis more frequently than secondary to any other infectious process during pregnancy \[[@B5]\]. Acute respiratory distress syndrome complicates approximately 1--8.5% of pyelonephritis cases \[[@B6], [@B7]\]. Frequently, an admission to an intensive care unit is necessary.

While the implications of pyelonephritis in the antepartum period are well described, there is little data about outcomes and complications when pyelonephritis occurs at the time of delivery \[[@B1]--[@B3], [@B8]--[@B11]\]. As these studies describe outcomes of pregnancies complicated by pyelonephritis, none of these describe specifically outcomes of patients who deliver during the admission during which they were diagnosed with pyelonephritis. The objective of this study was to expand on these studies, using a large nationwide data set, to estimate the medical, infectious, and obstetric complications associated with pyelonephritis at delivery.

2. Materials and Methods {#sec2}
========================

2.1. Study Design {#sec2.1}
-----------------

The Nationwide Inpatient Sample (NIS) from the Healthcare Cost and Utilization Project of the Agency for Healthcare Research and Quality (AHRQ) for years 2008--2010 was queried for all delivery discharges \[[@B12]\]. The NIS is the largest all-payer inpatient database in the United States and contains data from approximately 8 million hospital admissions from over 1,000 hospitals in 42 states (2008) to 45 states (2010). The hospitals in the NIS are stratified based on ownership, bed size, teaching status, urban/rural location, and region. From each stratum, the NIS contains approximately 20% of United States (US) hospitals, and the sampling frame comprises 90% of all US hospital discharges. The information included in the NIS is similar to that in a typical discharge summary with safeguards to protect the privacy of individual patients, physicians, and hospitals. Weighting estimates are included for each hospitalization that allows for national estimates to be made \[[@B12]\].

Using the NIS for each of the years 2008--2010, all records containing a delivery discharge were identified. A delivery admission was defined as a hospitalization that included a delivery code (International Classification of Diseases, 9th Revision, Clinical Modification \[ICD-9-CM\] codes 74 for cesarean section; 72, 73, and 75 for vaginal delivery; V27 or 650--659 for nonspecific delivery codes) \[[@B13], [@B14]\]. Deliveries were also identified by diagnosis-related group (DRG) codes. DRG codes 765 and 766 were utilized to identify cesarean deliveries and codes 767, 768, 774, and 775 for vaginal deliveries. The ICD-9-CM codes used to identify discharges with pyelonephritis were 590.0--590.9. To identify comorbidities, both the ICD-9-CM code for a particular condition in pregnancy and the general ICD-9-CM codes were used (Supplemental Table 1 of the Supplementary Material available online at <http://dx.doi.org/10.1155/2013/124102> for list of ICD-9-CM codes used).

2.2. Statistical Analysis {#sec2.2}
-------------------------

All admissions in the NIS for delivery were identified. Logistic regression analyses were used to compute odds ratios with 95% confidence intervals for age, race/ethnicity, medical conditions and events, and pregnancy-related complications among women with pyelonephritis compared to women without pyelonephritis. A multivariable logistic regression model was created controlling for age, insurance status, income quartile of residing ZIP code, and the studied preexisting medical conditions to identify the odds of various medical and obstetric complications among women with pyelonephritis compared to women without pyelonephritis. Race/ethnicity was not included in the final model due to the large number of entries in the NIS with missing race/ethnicity data. Statistical significance for all analyses was assigned as a *P* value \<0.05. Analyses were performed using SAS version 9.3 (SAS Institute Inc., Cary, NC) and GraphPad Prism 6.0 for Macintosh (GraphPad Software, San Diego, CA). This study protocol was reviewed and approved by the Duke University Medical Center Institutional Review Board as exempt research.

3. Results {#sec3}
==========

During the period from 2008 through 2010, there were estimated 12,628,746 deliveries in the NIS, of those, 26,397 patient records included a diagnosis of pyelonephritis at a delivery discharge. The overall rate of pyelonephritis during delivery admission for the years 2008 through 2010 was 2.1 per 1000 deliveries.

[Table 1](#tab1){ref-type="table"} describes demographic information in patients with and without pyelonephritis. Women with pyelonephritis during the delivery admission were more likely to be African American or Hispanic, were younger, less likely to have private insurance, and were more likely to reside in a ZIP code whose median income was in the lowest quartile ([Table 1](#tab1){ref-type="table"}). Race/ethnicity data was missing for 13.8% of women with pyelonephritis and for 15.5% of women without pyelonephritis.

[Table 2](#tab2){ref-type="table"} presents preexisting medical conditions associated with pyelonephritis. Women with pyelonephritis during the delivery admission were more likely to have cardiomyopathy, asthma, diabetes, systemic lupus erythematosus, anemia, thrombocytopenia, sickle cell disease/thalassemia, or chronic renal failure compared to women without pyelonephritis. Women with pyelonephritis during the delivery admission were also more likely to use drugs, alcohol, or tobacco compared to women without pyelonephritis.

Medical complications were common among women with pyelonephritis at delivery admission. Women with pyelonephritis had increased odds of acute heart failure, deep vein thrombosis, pulmonary edema, and acute renal failure compared to women without pyelonephritis. Infection complications were also common among women with pyelonephritis. Women with pyelonephritis at a delivery admission had increased odds of pneumonia, acute respiratory distress syndrome, and sepsis compared to women without pyelonephritis. In addition, women with pyelonephritis were more likely to have a transfusion and require mechanical ventilation compared to women without pyelonephritis ([Table 3](#tab3){ref-type="table"}).

Women with pyelonephritis were more likely to be carrying a multiple gestation or have their pregnancy complicated by preterm labor or chorioamnionitis compared to women without pyelonephritis. Cesarean delivery, gestational diabetes, preeclampsia/eclampsia/gestational hypertension, premature rupture of the membranes, and postpartum hemorrhage were all less common among women with pyelonephritis compared to women without pyelonephritis at the time of delivery admission ([Table 4](#tab4){ref-type="table"}).

[Table 5](#tab5){ref-type="table"} outlines the adjusted analysis for various medical and obstetric complications at delivery while controlling for age, insurance status, income of residing ZIP code, and pre-existing medical conditions in women who had pyelonephritis at the time of delivery. Most significantly, sepsis was 108 times more likely to occur among women with pyelonephritis compared to women without pyelonephritis. Other infectious complications remained significantly associated with pyelonephritis, including pneumonia, acute renal failure, pulmonary edema, and acute respiratory distress syndrome in our adjusted model. Multiple gestation, chorioamnionitis, and preterm labor were also more common in the pyelonephritis population.

4. Discussion {#sec4}
=============

Pyelonephritis is the most common nonobstetric indication for antepartum hospitalization and is a common source of maternal and neonatal morbidity \[[@B3]\]. Here, we demonstrate that pyelonephritis at delivery admission is also common. We reconfirm several well-known preexisting medical conditions that have been associated with pyelonephritis during pregnancy and further demonstrate that women with pyelonephritis at delivery admission are at increased risk for severe infectious complications, such as pneumonia, ARDS, and sepsis, and are also at increased risk for transfusion, requiring mechanical ventilation, acute heart failure, pulmonary edema, and acute renal failure. As our study utilized data from a large database representing the entire United States, the conclusions and findings from our analysis largely validate findings from previously noted smaller, single-center studies.

It is well known that women who develop pyelonephritis during pregnancy are at increased risk of sepsis and ARDS and require ICU admission compared to nonpregnant women who develop pyelonephritis \[[@B1]--[@B3], [@B5], [@B15]\]. Using the NIS, it became evident that these women are at markedly increased risk for these and other complications. Women with pyelonephritis during the delivery are over 100 times more likely to have sepsis than women who do not have pyelonephritis. Pneumonia was 18 times more likely in women with pyelonephritis, and ARDS and pulmonary edema were both 11 times more likely to occur in this population. There was no difference in the risk for pulmonary emboli or deep vein thrombosis, suggesting an inflammatory mechanism for lung injury not a coagulation-related mechanism. These findings illustrate that women with pyelonephritis at delivery are at risk for significant morbidity.

Belkin et al. utilized the NIS from a single year, 2006, to identify demographic data among women admitted at any time during pregnancy with pyelonephritis \[[@B15]\]. Similar to our study, they found that women less than 20 and women of African American or Hispanic race/ethnicity were at higher risk for pyelonephritis in pregnancy, though they did not compare these demographics to women without pyelonephritis. They found that women with pyelonephritis had associated risk for sepsis (2.0%), anemia (22.4%), diabetes (3.7%), and preterm labor (3.8%), but again, they did not determine the rate of these outcomes among women without pyelonephritis \[[@B15]\]. In our study, by analyzing data only at admissions for delivery, rather than at antepartum admission, we were able to estimate outcomes for individuals, rather than hospitalizations, as women could possibly have more than one antepartum hospitalization during a pregnancy but only a single hospitalization per woman per pregnancy. Additionally, by examining discharge data, obstetric outcomes data could be captured, which would not be available using antepartum discharges. Lastly, we were able to calculate ORs for associated complications among women with pyelonephritis since we also determined the rates of these events in pregnant women at delivery without pyelonephritis.

Our study has limitations. Our findings rely on a large discharge database, and therefore we are unable to determine if the associated preexisting medical conditions caused pyelonephritis, or if pyelonephritis was causative of the observed medical and obstetric events that were more common among women with pyelonephritis. Regardless, our data demonstrate that pyelonephritis is at least associated with these events. Next, there is no way to ascertain if coded preexisting medical conditions were active at the time of delivery. Furthermore, preexisting conditions or medical/obstetric events occurring at delivery would have been missed if the variable was not coded. Therefore, we may be underrepresenting some conditions or events. Finally, neonatal discharge records are not linked to maternal discharge records within the NIS; thus, we are unable to provide information on neonatal outcomes among those neonates born to women with pyelonephritis.

Discharge databases are also open to questions regarding the accuracy of coding. Yasmeen et al. recently assessed the accuracy and reliability of obstetric discharge databases and found them to provide helpful information \[[@B16]\]. Thus, despite the limitations of the NIS database, the study design allows the examination or relatively rare disorders using a large numbers of pregnancies. In doing so, odds ratios and maternal morbidity rates for medical conditions, pregnancy-related conditions, and pregnancy outcomes that would have otherwise been difficult to quantify can be estimated. Our multivariable logistic regression model attempted to identify an independent association of pyelonephritis with various medical and obstetric outcomes. In doing so, we controlled for clinically relevant preexisting medical conditions and social factors that are known to be commonly associated with pyelonephritis. In using a database such as the NIS, it is impossible to account for all potential confounders, and as such we acknowledge this limitation.

In summary, this dataset reaffirms many of the known risk factors for pyelonephritis, including minority race, young age, lower socioeconomic status, nongestational diabetes, and sickle cell disease, but also uniquely examines preexisting medical conditions and medical and obstetric complications among women with pyelonephritis occurring at delivery. Many women with pyelonephritis at delivery were found to have other associated infectious complications such as sepsis, pneumonia, and acute respiratory distress syndrome. It is unknown if pyelonephritis was directly causative of these outcomes, and future research is warranted.

Supplementary Material {#supplementary-material-sec}
======================

###### 

Supplemental Table 1: ICD-9 codes for pre-existing medical conditions, medical events, and obstetric complications utilized to identify cases in the NIS 2008 -- 2010.

###### 

Click here for additional data file.

This paper was presented at the 2013 Annual Meeting of the Infectious Diseases Society for Obstetrics and Gynecology (IDSOG), Santa Ana Pueblo, NM, August 8--10, 2013.

The authors report no conflict of interests.

###### 

Demographic data at the time of delivery in hospital discharges among women with pyelonephritis compared to women without pyelonephritis, Nationwide Inpatient Sample years 2008--2010 (12,628,746 deliveries).

  -------------------------------------------------------------------------------------------------------------------------------------------------
                                                                     Pyelo\                  No Pyelo\               OR (95% CI)      *P* value
                                                                     *n* = 26,397            *n* = 12,602,349                         
  ------------------------------------------------------------------ ----------------------- ----------------------- ---------------- -------------
  Race/ethnicity, *n* (%)                                                                                                              

   Caucasian                                                         9436 (35.7)             5,561,876 (44.1)        1.0              ---

   African American                                                  3948 (14.9)             1,507,268 (12.0)        1.5 (1.5, 1.6)   \<0.0001

   Hispanic                                                          7644 (29.0)             2,418,562 (19.2)        1.9 (1.8, 1.9)   \<0.0001

   Other                                                             1738 (6.6)              1,161,608 (9.2)         0.9 (0.8, 0.9)   \<0.0001

   Missing                                                           3634 (13.8)             1,953,036 (15.5)        ---              ---

  Age, yrs^a,e^                                                      24.9 ± 14.5             27.6 ± 13.7             ---              \<0.0001

  Private insurance, *n* (%)^e^                                      7421 (28.1)             6,252,591 (49.6)        0.4 (0.4, 0.4)   \<0.0001

  Median house income in ZIP code of lowest quartile, *n* (%)^d,e^   9192 (34.8)             3,331,368 (26.4)        1.5 (1.5, 1.5)   \<0.0001

  LOS, days^b,e^                                                     3 (2, 4)                2 (2, 3)                ---              \<0.0001^c^

  Total charges, \$^b,e^                                             11,175 (7030, 19,174)   10,000 (6785, 15,090)   ---              \<0.0001^c^
  -------------------------------------------------------------------------------------------------------------------------------------------------

^a^Values are mean ± SD.

^b^Values are median (quartile).

^c^Wilcoxon rank sum.

^d^Median house income in ZIP code of lowest quartile defined as median income in subject\'s ZIP code \$1--\$38,999.

^e^The numbers of missing variables for each demographic descriptor are listed as follows for women with and without pyelonephritis, respectively: age (10 \[0.04%\] and 13,490 \[0.1%\]), insurance status (50 \[0.2%\] and 17,975 \[0.1%\]), house income status (475 \[1.8%\] and 253,740 \[2.0%\]), LOS (0 \[0%\] and 430 \[0.003%\]), and total charges (630 \[2.4%\] and 288,585 \[2.3%\]).

###### 

Preexisting medical conditions present at time of delivery in hospital discharges among women with pyelonephritis compared to women without pyelonephritis, Nationwide Inpatient Sample years 2008--2010 (12,628,746 deliveries).

  ----------------------------------------------------------------------------------------------------
  Condition, *n* (%)                   Pyelo\         No Pyelo\          OR (95% CI)       *P* value
                                       *n* = 26,397   *n* = 12,602,349                     
  ------------------------------------ -------------- ------------------ ----------------- -----------
  Heart disease                                                                             

   Cardiomyopathy                      39 (0.1)       5705 (0.04)        3.3 (2.4, 4.4)    \<0.0001

   Valvular heart disease              108 (0.4)      55,209 (0.4)       0.9 (0.8, 1.1)    0.513

  Pulmonary disease                                                                         

   Asthma                              1423 (5.4)     410,193 (3.3)      1.7 (1.6, 1.8)    \<0.0001

  Endocrine disorders                                                                       

   Diabetes (nongestational)           560 (2.1)      133,796 (1.1)      2.0 (1.9, 2.2)    \<0.0001

   Thyroid disorder                    510 (1.9)      299,418 (2.4)      0.8 (0.7, 0.9)    \<0.0001

  Autoimmune disorders                                                                      

   Systemic lupus erythem.             77 (0.3)       16,596 (0.1)       2.2 (1.7, 2.7)    \<0.0001

  Hematologic disorders                                                                     

   Thrombophilia/APS                   141 (0.5)      71,313 (0.6)       0.9 (0.8, 1.1)    0.516

   Anemia                              5406 (20.5)    1,358,360 (10.8)   2.1 (2.1, 2.2)    \<0.0001

   Thrombocytopenia                    443 (1.7)      114,254 (0.9)      1.9 (1.7, 2.0)    \<0.0001

   Sickle cell/thalassemia             86 (0.3)       19,559 (0.1)       2.1 (1.7, 2.6)    \<0.0001

  Drugs/alcohol/tobacco                                                                     

   Drug use                            852 (3.2)      164,788 (1.3)      2.5 (2.3, 2.7)    \<0.0001

   Alcohol use                         56 (0.2)       14,034 (0.1)       1.9 (1.5, 2.5)    \<0.0001

   Tobacco                             2531 (9.6)     792,389 (6.3)      1.6 (1.5, 1.6)    \<0.0001

  Chronic hypertension/renal failure                                                        

   Chronic hypertension                488 (1.8)      248,440 (2.0)      0.9 (0.8, 1.02)   0.148

   Chronic renal failure               40 (0.1)       5012 (0.04)        3.8 (2.8, 5.1)    \<0.0001
  ----------------------------------------------------------------------------------------------------

APS: antiphospholipid antibody syndrome.

###### 

Medical events present at time of delivery in hospital discharges among women with pyelonephritis compared to women without pyelonephritis, Nationwide Inpatient Sample years 2008--2010 (12,628,746 deliveries).

  ---------------------------------------------------------------------------------------------------
  Condition, *n* (%)                Pyelo\         No Pyelo\          OR (95% CI)         *P* value
                                    *n* = 26,397   *n* = 12,602,349                       
  --------------------------------- -------------- ------------------ ------------------- -----------
  Transfusion                       793 (3.0)      130,911 (1.0)      2.9 (2.7, 3.2)      \<0.0001

  Mechanical ventilation            221 (0.8)      8807 (0.07)        12.1 (10.6, 13.8)   \<0.0001

  Cardiac events                                                                           

   Acute heart failure              67 (0.2)       4523 (0.04)        7.1 (5.5, 8.9)      \<0.0001

  Pulmonary events                                                                         

   Pneumonia                        635 (2.4)      12,589 (0.1)       24.7 (22.7, 26.7)   \<0.0001

   Pulmonary edema                  55 (0.2)       2008 (0.02)        13.0 (9.8, 16.9)    \<0.0001

   Acute respiratory distress syn   88 (0.3)       2798 (0.02)        15.0 (12.1, 18.5)   \<0.0001

  Thromboembolic Events                                                                    

   Pulmonary embolism               11 (0.04)      3609 (0.03)        1.3 (0.6, 2.3)      0.405

   Deep vein thrombosis             22 (0.08)      6352 (0.05)        1.6 (1.03, 2.4)     0.022

  Infections                                                                               

   Sepsis                           1393 (5.3)     5426 (0.04)        129 (122, 137)      \<0.0001

  Renal event                                                                              

   Acute renal failure              257 (1.0)      6828 (0.05)        18.1 (15.9, 20.5)   \<0.0001
  ---------------------------------------------------------------------------------------------------

###### 

Obstetric events present at time of delivery in hospital discharges among women with pyelonephritis compared to women without pyelonephritis, Nationwide Inpatient Sample years 2008--2010 (12,628,746 deliveries).

  ------------------------------------------------------------------------------------------------
  Condition, *n* (%)                Pyelo\         No Pyelo\          OR (95% CI)      *P* value
                                    *n* = 26,397   *n* = 12,602,349                    
  --------------------------------- -------------- ------------------ ---------------- -----------
  Obstetric events                                                                      

   Cesarean delivery                3669 (13.9)    4,037,688 (32.0)   0.3 (0.3, 0.3)   \<0.0001

   Operative vaginal delivery       645 (2.4)      791,598 (6.3)      0.4 (0.3, 0.4)   \<0.0001

   Multiple gestation               1392 (5.3)     265,839 (2.1)      2.6 (2.4, 2.7)   \<0.0001

   GDM                              982 (3.7)      714,105 (5.7)      0.6 (0.6, 0.7)   \<0.0001

   Prex, eclamp, gest HTN           1271 (4.8)     929,959 (7.4)      0.6 (0.6, 0.7)   \<0.0001

   Preterm labor                    3696 (14.0)    1,048,007 (8.3)    1.8 (1.7, 1.9)   \<0.0001

   Premature rupture of membranes   440 (1.7)      469,115 (3.7)      0.4 (0.4, 0.5)   \<0.0001

   Postpartum hemorrhage            375 (1.4)      321,599 (2.5)      0.5 (0.5, 0.6)   \<0.0001

   Chorioamnionitis                 1285 (4.9)     322,282 (2.5)      1.9 (1.8, 2.1)   \<0.0001
  ------------------------------------------------------------------------------------------------

Eclamp: eclampsia; GDM: gestational diabetes; gest HTN: gestational hypertension; prex: preeclampsia.

###### 

Multivariable logistic regression analysis for the listed outcomes among women with pyelonephritis compared to women without pyelonephritis, while controlling for age, private insurance, residing in a ZIP code with annual income at lowest quartile, cardiomyopathy, asthma, diabetes, thyroid disorders, systemic lupus erythematous, anemia, thrombocytopenia, sickle cell disease, drug use, alcohol use, tobacco use, chronic hypertension, and chronic renal failure.

  --------------------------------------------------------------------
                                    Adjusted OR (95% CI)   *P* value
  --------------------------------- ---------------------- -----------
  Transfusion                       1.8 (1.7, 2.0)         \<0.0001

  Mechanical ventilation            10.9 (9.5, 12.5)       \<0.0001

  Cardiac events                                            

   Acute heart failure              6.5 (4.9, 8.5)         \<0.0001

  Pulmonary events                                          

   Pneumonia                        18.5 (17.0, 20.1)      \<0.0001

   Pulmonary edema                  11.3 (8.6, 14.9)       \<0.0001

   Acute respiratory distress\      11.6 (9.3, 14.3)       \<0.0001
   syndrome                                                

  Thromboembolic events                                     

   Pulmonary embolism               1.1 (0.6, 2.0)         0.858

   Deep vein thrombosis             1.6 (1.02, 2.4)        0.038

  Infections                                                

   Sepsis                           108 (101, 115)         \<0.0001

  Renal event                                               

   Acute renal failure              14.7 (12.9, 16.7)      \<0.0001

  Obstetric events                                          

   Cesarean delivery                0.3 (0.2, 0.4)         \<0.0001

   Operative vaginal delivery       0.4 (0.3, 0.4)         \<0.0001

   Multiple gestation               2.9 (2.8, 3.1)         \<0.0001

   GDM                              0.7 (0.7, 0.8)         \<0.0001

   Prex, eclamp, gest HTN           0.6 (0.5, 0.6)         \<0.0001

   Preterm labor                    1.7 (1.5, 1.8)         \<0.0001

   Premature rupture of membranes   0.4 (0.4, 0.5)         \<0.0001

   Postpartum hemorrhage            0.4 (0.4, 0.5)         \<0.0001

   Chorioamnionitis                 1.7 (1.6, 1.8)         \<0.0001
  --------------------------------------------------------------------

Eclamp: eclampsia; GDM: gestational diabetes; gest HTN: gestational hypertension; Prex: preeclampsia.
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